AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2018
Mar 9, 2018
32106_dirs_2018-03-09_e5299279-8ff3-4d8d-80c6-3ac0084481bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2018-03-08
Reporting Person: DE GREEF RODERICK (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-08 | Employee Stock Option | $1.64 | A | 171919 | Acquired | 2021-12-20 | Common Stock (171919) | Direct |
Footnotes
F1: As disclosed in the registrants annual report on Form 10-K for the year ended December 31, 2016, on December 20, 2016, the reporting person was granted an option to purchase 171,919 shares of common stock. The option vests in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019. No Form 4 filing was required upon the initial grant of the option because the option was subject to vesting based on conditions that were not tied to the passage of time and continued employment and not tied directly to the market price of the registrant's common stock.